Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activated STING in the thymic epithelium alters T cell development and selection leading to autoimmunity
Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum
Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum
View: Text | PDF
Research Article Autoimmunity Immunology

Activated STING in the thymic epithelium alters T cell development and selection leading to autoimmunity

  • Text
  • PDF
Abstract

Coatomer protein complex subunit α (COPA) syndrome is a monogenic disorder of immune dysregulation that leads to interstitial lung disease and high-titer autoantibodies. Constitutive activation of the innate immune molecule stimulator of interferon genes (STING) is centrally involved in disease. However, the mechanisms by which STING results in autoimmunity are not well understood in COPA syndrome and other STING-associated diseases. Prior studies showed a cell autonomous role for STING in thymocyte development. Single-cell data of human thymus demonstrated that STING is highly expressed in medullary thymic epithelial cells (mTECs) and at levels much greater than in T cells. Here, we show that in certain contexts, activated STING exerts a functional role in the thymic epithelium to alter thymocyte selection and predisposes to autoimmunity. In CopaE241K/+ mice, activated STING in mTECs amplified IFN signaling, impaired macroautophagy, and caused a defect in negative selection of T cell precursors. WT mice given a systemic STING agonist phenocopied the selection defect and showed enhanced thymic escape of a T cell clone targeting a self-antigen also expressed in melanoma. Our work demonstrates that STING activation in TECs shapes the T cell repertoire and contributes to autoimmunity, findings that are important for conditions that activate thymic STING.

Authors

Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum

×

Figure 4

Activated STING impairs negative selection of T cells and alters the T cell repertoire.

Options: View larger image (or click on image) Download as PowerPoint
Activated STING impairs negative selection of T cells and alters the T c...
(A) Left: representative flow analysis of CD4+ and CD8+ on reconstituted thymocytes in bone marrow chimeras. Right: percentage of CD4+ SP thymocytes among the reconstituted thymocytes (OT-II→Rip-mOVA × WT, n = 11; OT-II→Rip-mOVA × CopaE241K/+, n = 5; WT→Rip-mOVA × WT × Stinggt/gt, n = 10; WT→Rip-mOVA × CopaE241K/+ × Stinggt/gt, n = 4). (B) Left: flow analysis of TCR-β and Nur77 expression in the reconstituted CD4+ SP in the bone marrow chimeras. Right: percentage of Nur77+ population among CD4+ SP thymocytes (OT-II→Rip-mOVA × WT, n = 7; OT-II→Rip-mOVA × CopaE241K/+, n = 5; WT→Rip-mOVA × WT × Stinggt/gt, n = 8; WT→Rip-mOVA × CopaE241K/+ × Stinggt/gt, n = 4). (C) Left: flow analysis of Vβ5 and Vα2 in CD4+ SP thymocytes in the bone marrow chimeras shown in (A). Right: ratio of TCRhi versus TCRlo among CD4+ SP thymocytes. (D) Left: flow analysis of CD25 and Foxp3 in CD4+ thymocytes in the bone marrow chimeras. Right: percentage of thymic Tregs among CD4+ thymocytes (OT-II→Rip-mOVA × WT, n = 7; OT-II→Rip-mOVA × CopaE241K/+, n = 5; WT→Rip-mOVA × WT × Stinggt/gt, n = 8; WT→Rip-mOVA × CopaE241K/+ × Stinggt/gt, n = 4). Data were pooled from 3 independent experiments. Data are mean ± SD. One-way ANOVA and Bonferroni’s multiple-comparison test (log normal distribution in D) were used for statistical analysis. A P value of less than 0.05 was considered statistically significant. All host mice are on Rip-mOVA background.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts